Changes in dynorphin immunoreactivity but unaltered density of enkephalin immunoreactive neurons in basal ganglia nuclei of genetically dystonic hamsters

Synapse

Volumn 65, Issue 11, 2011, Pages 1196-1203

  Kreil, Annette ^a   Hamann, Melanie ^a   Sander, Svenja E ^a   Richter, Angelika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Animal models; Basal ganglia; Dyskinesia; Dystonia; Movement disorder

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DYNORPHIN; ENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CELL DENSITY; CONTROLLED STUDY; CORPUS STRIATUM; DYSTONIA; FEMALE; GABAERGIC SYSTEM; HAMSTER; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; NONHUMAN; PRIORITY JOURNAL; THALAMUS NUCLEUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASAL GANGLIA; CRICETINAE; DISEASE MODELS, ANIMAL; DYNORPHINS; DYSTONIA; ENKEPHALINS; FEMALE; INTERNEURONS; MALE; MESOCRICETUS; NEURONS;

EID: 80052353185     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20959     Document Type: Article

References (54)

1. Abercrombie M. 1946. Estimation of nuclear population from microtome sections. Anat Rec 94: 239-247.
2. Alexander GE, Crutcher MD, DeLong MR. 1990. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85: 119-146.
3. Angulo JA, McEwen BS. 1994. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Brain Res Rev 19: 1-28.
4. Bennay M, Gernert M, Richter A. 2001. Spontaneous remission of paroxysmal dystonia coincides with normalization of entopeduncular activity in dt(SZ) mutants. J Neurosci 21: RC153.
5. Bolam JP, Hanley JJ, Booth PA, Bevan MD. 2000. Synaptic organisation of the basal ganglia. J Anat 196 (Part 4): 527-542.
6. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. 2008. The pathophysiological basis of dystonias. Nat Rev Neurosci 9: 222-234.
7. Brugos B, Hochhaus G. 2004. Metabolism of dynorphin A (1-13). Pharmazie 59: 339-343.
8. Calon F, Di Paolo T. 2002. Levodopa response motor complications-GABA receptors and preproenkephalin expression in human brain. Parkinsonism Relat Disord 8: 449-454.
9. Fahn S, Bressman SB, Marsden CD. 1998. Classification of dystonia. Adv Neurol 78: 1-10.
10. Fallon JH, Leslie FM. 1986. Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249: 293-336.
11. Fedrowitz M, Hamann M, Rehders JH, Richter A, Gernert M. 2002. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia. J Neurosci Res 68: 595-603.
12. French SJ, Hailstone JC, Totterdell S. 2003. Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res 981: 160-167.
13. Galvan A, Wichmann T. 2007. GABAergic circuits in the basal ganglia and movement disorders. Prog Brain Res 160: 287-312.
14. Gantois I, Fang K, Jiang L, Babovic D, Lawrence AJ, Ferreri V, Teper Y, Jupp B, Ziebell J, Morganti-Kossmann CM, O'Brien TJ, Nally R, Schütz G, Waddington J, Egan GF, Drago J. 2007. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc Natl Acad Sci USA 104: 4182-4187.
15. Gernert M, Richter A, Löscher W. 1999a. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters. Brain Res 821: 277-285.
16. Gernert M, Richter A, Löscher W. 1999b. In vivo extracellular electrophysiology of pallidal neurons in dystonic and nondystonic hamsters. J Neurosci Res 57: 894-905.
17. Gernert M, Richter A, Löscher W. 1999c. Subconvulsive dose of pentylenetetrazole increases the firing rate of substantia nigra pars reticulata neurons in dystonic but not in nondystonic hamsters. Synapse 33: 259-267.
18. Gernert M, Hamann M, Bennay M, Löscher W, Richter A. 2000. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J Neurosci 20: 7052-7058.
19. Gernert M, Bennay M, Fedrowitz M, Rehders JH, Richter A. 2002. Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia. J Neurosci 22: 7244-7253.
20. Graybiel AM, Chesselet MF. 1984. Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity. Proc Natl Acad Sci USA 81: 7980-7984.
21. Hallett M. 2011. Neurophysiology of dystonia: The role of inhibition. Neurobiol Dis 42: 177-184.
22. Hamann M, Richter A. 2004. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia. Neurobiol Dis 16: 78-84.
23. Hamann M, Sander SE, Richter A. 2005. Age-dependent alterations of striatal calretinin interneuron density in a genetic animal model of primary paroxysmal dystonia. J Neuropathol Exp Neurol 64: 776-781.
24. Hamann M, Raymond R, Varughesi S, Nobrega JN, Richter A. 2006. Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia. Brain Res 1099: 176-182.
25. Hamann M, Richter A, Meillasson FV, Nitsch C, Ebert U. 2007. Age-related changes in parvalbumin-positive interneurons in the striatum, but not in the sensorimotor cortex in dystonic brains of the dt(sz) mutant hamster. Brain Res 1150: 190-199.
26. sz mutant hamsters reflects differences in striatal metabolism between severe and mild dystonia. J Neurosci Res 87: 776-783.
27. Koos T, Tepper JM, Wilson CJ. 2004. Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. J Neurosci 24: 7916-7922.
28. Kreitzer AC. 2009. Physiology and pharmacology of striatal neurons. Annu Rev Neurosci 32: 127-147.
29. Lavin A, Garcia-Munoz M. 1986. Electrophysiological changes in substantia nigra after dynorphin administration. Brain Res 369: 298-302.
30. Mallet N, Le Moine C, Charpier S, Gonon F. 2005. Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J Neurosci 25: 3857-3869.
31. McGinty JF. 2007. Co-localization of GABA with other neuroactive substances in the basal ganglia. Prog Brain Res 160: 273-284.
32. Middleton FA, Strick PL. 2000. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 31: 236-250.
33. Morin LP, Wood RI. 2001. A stereotaxic atlas of the golden hamster brain. San Diego, New York, London: Academic Press.
34. Morissette M, Goulet M, Soghomonian JJ, Blanchet PJ, Calon F, Bédard PJ, Di Paolo T. 1997. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: Comparison with L-DOPA therapy. Brain Res Mol Brain Res 49: 55-62.
35. Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T. 1999. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. J Neurochem 72: 682-692.
36. Nadjar A, Brotchie JM, Guigoni C, Li Q, Zhou S, Wang G, Ravenscroft P, Georges F, Crossman AR, Bezard E. 2006. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: A call for a reappraisal of the functional organization of the basal ganglia. J Neurosci 26: 8653-8661.
37. Nakano K, Kayahara T, Tsutsumi T, Ushiro H. 2000. Neural circuits and functional organization of the striatum. J Neurol 247 (Suppl 5): V1-V15.
38. Nardocci N, Fernandez-Alvarez E, Wood NW, Spacy SD, Richter A. 2002. The paroxysmal dyskinesias. In: Guerrini R, Aicardi J, Andermann F, Hallet M, editors. Epilepsy and movement disorders. Cambridge: Cambridge University Press. p 125-139.
39. Neychev VK, Gross RE, Lehéricy S, Hess EJ, Jinnah HA. 2011. The functional neuroanatomy of dystonia. Neurobiol Dis 42: 185-201.
40. Nobrega JN, Parkes JH, Wong P, Raymond R, Richter A. 2004. Altered expression of preproenkephalin and prodynorphin mRNA in a genetic model of paroxysmal dystonia. Brain Res 1015: 87-95.
41. Pickel VM, Sumal KK, Beckley SC, Miller RJ, Reis DJ. 1980. Immunocytochemical localization of enkephalin in the neostriatum of rat brain: A light and electron microscopic study. J Comp Neurol 189: 721-740.
42. Raike RS, Jinnah HA, Hess EJ. 2005. Animal models of generalized dystonia. NeuroRx 2: 504-512.
43. Reiner A, Anderson KD. 1990. The patterns of neurotransmitter and neuropeptide co-occurence among striatal projection neurons: Conclusions based on recent findings. Brain Res Rev 15: 251-265.
44. Richter A. 2005. The genetically dystonic hamster: An animal model of paroxysmal dystonia. In: LeDoux M, editor. Animal models of movement disorders. Amsterdam, New York: Elsevier Academic Press. p 459-466.
45. Richter A, Löscher W. 1993. The kappa-opioid receptor agonist. U50, 488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia. Eur J Pharmacol 236: 289-294.
46. Richter A, Löscher W. 1998. Pathophysiology of idiopathic dystonia: Findings from genetic animal models. Prog Neurobiol 54: 633-677.
47. Sander SE, Hamann M, Richter A. 2006. Age-related changes in striatal nitric oxide synthase-immunoreactive interneurons in the dystonic dtsz mutant hamster. Neuropathol Appl Neurobiol 32: 74-82.
48. Sar M, Stumpf WE, Miller RJ, Chang KJ, Cuatrecasas P. 1978. Immunohistochemical localization of enkephalin in rat brain and spinal cord. J Comp Neurol 182: 17-37.
49. Son DD, Harlan RE. 1993. Ontogeny of the proenkephalin system in the rat corpus striatum: Its relationship to dopaminergic innervation and transient compartmental expression. Neuroscience 52: 883-909.
50. Standaert DG. 2011. Update on the pathology of dystonia. Neurobiol Dis 42: 148-151.
51. Steiner H, Gerfen CR. 1998. Role of dynorphin and enkephalin in the regulation of striatal ouput pathways and behavior. Exp Brain Res 123: 60-76.
52. Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T. 2010. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. Neuropharmacol 58: 286-296.
53. Tepper JM, Wilson CJ, Koós T. 2008. Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons. Brain Res Rev 58: 272-281.
54. Whone AL, Von Spiczak S, Edwards M, Valente EM, Hammers A, Bhatia KP, Brooks DJ. 2004. Opioid binding in DYT1 primary torsion dystonia: An 11C-diprenorphine PET study. Mov Disord 19: 1498-1503.